Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | IIIN | CRS |
|---|---|---|
| Price | $29.59 | $391.17 |
| Change today | ▼ 1.92% | ▼ 1.15% |
| Market cap | $572.81M | $19.39B |
| Return, 3 months | +1.0% | -33.8% |
| Return, year to date | -6.3% | +24.4% |
| Return, 1 year | -20.7% | +50.8% |
| P/E (TTM) | 15.8 | 37.2 |
| P/B | 1.5 | 8.7 |
| P/E percentile vs own 5y | 56th | 56th |
| Dividend yield | 0.41% | 0.20% |
| Revenue growth (YoY, latest qtr) | +9.9% | +12.6% |
| Net profit growth (YoY) | -40.5% | +45.4% |
| Gross margin | 11.8% | 30.6% |
| Operating margin | 6.6% | 22.5% |
| Net margin | 5.1% | 17.0% |
| Return on equity | 10.0% | 25.7% |
| Analyst target vs. price | – | +56.9% |
| Analyst buy share | – | 86% |
| RSI (14) | 46 | 32 |
| 30-day volatility | 19.6% | 26.9% |
| Max drawdown, 1 year | -35.7% | -38.0% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
